Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Coriolus versicolor-based vaginal gel

A vaginal gel consisting of hyaluronic acid niosomes, beta-glucan niosomes, alpha-oligoglycan, Coriolus versicolor, Azadirachta indica extract, Centella asiatica and Aloe vera, with protective and repairing activities. Upon vaginal administration, the Coriolus versicolor-based vaginal gel may repair and improve re-epithelization of the cervical-vaginal mucosa with lesions that were caused by human papillomavirus (HPV) and may aid in the clearance of HPV-induced lesions. This may normalize HPV-dependent cervical lesions, prevent integration of HPV and HPV infection. It may also re-balance the vaginal microbiota and improve vaginal health.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:papilocare vaginal gel
Foreign brand name:Papilocare gel
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search